Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study - Top-Institutions - MDSpire

Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study

  • By

  • Xiaola Xue

  • Juyi Wu

  • Zhenpeng Tan

  • Chunyu Tian

  • Qiong Li

  • Shujuan Zhou

  • Yuchao Xia

  • Shaojie Yang

  • Xuan Yang

  • June 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, Washington

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #2

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology
    • HIV Research

  • #3

    University of Milan
    University of Milan

    Milan, Italy

    Key Differentiators

    • Oncology

  • #4

    European Institute of Oncology
    European Institute of Oncology

    Milan, Italy

    Key Differentiators

    • Oncology

  • #5

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Oncology

Original Source(s)

Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study

  • by Xiaola Xue, Juyi Wu, Zhenpeng Tan, Chunyu Tian, Qiong Li, Shujuan Zhou, Yuchao Xia, Shaojie Yang, Xuan Yang

  • June 24, 2026

Related Content

Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients

Palliative Care Coaching for Family Caregivers of Patients With Advanced Cancer: A Randomized Clinical Trial

Radiomics-based interpretable machine learning model from multiphasic CT imaging for predicting pathological grade in upper tract urothelial carcinoma: a multicenter study